相关实验视频
Updated: Jun 25, 2025

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
7.7K
关于欧洲前列腺癌查成本效益的系统审查
Pieter Vynckier1, Lieven Annemans1, Sarah Raes1
1Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
European urology
|May 24, 2024
概括
欧洲的前列腺癌 (PCa) 查可能具有成本效益,特别是基于风险的方法和MRI. 需要进一步的研究才能充分理解成本效益的决定因素.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 前列腺癌 (PCa) 是欧洲男性最常见的癌症.
- 查计划对于降低PCa的医疗保健成本,发病率和死亡率至关重要.
- 本综述提供了欧洲PCa查计划成本和收益的当代概述.
研究的目的:
- 系统地审查欧洲前列腺癌查计划的成本效益.
- 为了确定前列腺癌的成本有效的查策略.
主要方法:
- 使用PICO方法进行了系统的文献搜索.
- 在数据库中搜索了欧洲PCa查的经济评估.
- 关键搜索词包括"PCa"",选"和"成本效益".
主要成果:
- 确定了19项关于欧洲PCa查成本效益的研究.
- 基于风险和MRI增强的查显示了潜在的成本效益.
- 每个QALY的增量成本比率 (ICER) 从5872欧元到372,948欧元不等,平均值为56,487欧元.
结论:
- 结合基于风险的方法和MRI的查计划显示出具有成本效益的潜力.
- 以风险为基础的查,其次是MRI似乎比不进行查更具成本效益.
- 关于PCa查成本效益的知识差距存在,需要进一步调查.
更多相关视频
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
163
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
相关概念视频
Disorders of the Male Reproductive System
395
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
395
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343